四連板*ST河化(000953.SZ):下屬公司為藥物磷酸氯喹關鍵中間體主要生產廠家
格隆匯2月20日丨*ST河化(000953.SZ)公佈,公司股票連續4個交易日漲停。
根據2月19日最新發布的《新型冠狀病毒肺炎診療方案(試行第六版)》,新增磷酸氯喹作為治療新型冠狀病毒肺炎的試用藥物。公司下屬公司重慶南鬆凱博生物製藥有限公司作為上述藥物的關鍵中間體氯喹側鏈的主要生產廠家,目前正積極做好原材料、人員的調配,在嚴格遵守疫情防控要求的前提下,加強與有關部門溝通協調,推進復產進度。同時做好現有庫存的調配,儘可能滿足市場供應。由於此次疫情發展尚有較大不確定性,對公司產品需求量尚不明確,暫無法準確評估其對公司經營業績的影響。敬請廣大投資者注意投資風險。
公司正在實施重大資產重組,涉及收購重慶南鬆醫藥科技有限公司控股權及對公司尿素的相關業務、資產及負債置出。已完成了相關資產及股權交割和工商變更登記工作,目前正在推進非公開發行股份募集配套資金工作。
公司控股股東母公司銀億集團有限公司、控股股東寧波銀億控股有限公司向浙江省寧波市中級人民法院申請重整已獲受理。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.